Chiara Tarantelli

1.8k total citations
75 papers, 912 citations indexed

About

Chiara Tarantelli is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Chiara Tarantelli has authored 75 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 29 papers in Pathology and Forensic Medicine and 23 papers in Genetics. Recurrent topics in Chiara Tarantelli's work include Lymphoma Diagnosis and Treatment (28 papers), Chronic Lymphocytic Leukemia Research (23 papers) and Protein Degradation and Inhibitors (21 papers). Chiara Tarantelli is often cited by papers focused on Lymphoma Diagnosis and Treatment (28 papers), Chronic Lymphocytic Leukemia Research (23 papers) and Protein Degradation and Inhibitors (21 papers). Chiara Tarantelli collaborates with scholars based in Switzerland, Italy and United States. Chiara Tarantelli's co-authors include Francesco Bertoni, Eugenio Gaudio, Anastasios Stathis, Luciano Cascione, Emanuele Zucca, Andrea Rinaldi, Filippo Spriano, Elena Bernasconi, Ivo Kwee and Afua A. Mensah and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Chiara Tarantelli

69 papers receiving 898 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Chiara Tarantelli	630	247	207	157	105	75	912
Zhongzheng Lu	392 0.6×	121 0.5×	156 0.8×	67 0.4×	82 0.8×	11	642
Aaron Nguyen	695 1.1×	207 0.8×	421 2.0×	48 0.3×	79 0.8×	21	966
Kazuto Togitani	474 0.8×	266 1.1×	248 1.2×	53 0.3×	80 0.8×	30	892
Fankai Meng	612 1.0×	327 1.3×	111 0.5×	89 0.6×	56 0.5×	70	1.1k
Yoko Inaguma	167 0.3×	161 0.7×	120 0.6×	96 0.6×	47 0.4×	25	437
Houda Alachkar	613 1.0×	192 0.8×	190 0.9×	84 0.5×	41 0.4×	60	1.0k
Ella Willenbacher	273 0.4×	233 0.9×	301 1.5×	67 0.4×	205 2.0×	32	735
Guangxun Gao	463 0.7×	192 0.8×	149 0.7×	95 0.6×	53 0.5×	65	802
Louise F. Momparler	1.1k 1.7×	153 0.6×	338 1.6×	42 0.3×	56 0.5×	36	1.3k

Countries citing papers authored by Chiara Tarantelli

Since Specialization

Citations

This map shows the geographic impact of Chiara Tarantelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Tarantelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Tarantelli more than expected).

Fields of papers citing papers by Chiara Tarantelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Tarantelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Tarantelli. The network helps show where Chiara Tarantelli may publish in the future.

Co-authorship network of co-authors of Chiara Tarantelli

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Tarantelli. A scholar is included among the top collaborators of Chiara Tarantelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Tarantelli. Chiara Tarantelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sasi, Binu K., Chiara Tarantelli, Giulio Sartori, et al.. (2025). Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies. Haematologica. 110(12). 2974–2985. 1 indexed citations

Spriano, Filippo, Chiara Tarantelli, Eugenio Gaudio, et al.. (2024). Targeting CD25 + lymphoma cells with the antibody–drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agents. British Journal of Haematology. 205(5). 1873–1882. 2 indexed citations

Zammarchi, Francesca, Karin Havenith, Narinder Janghra, et al.. (2024). ADCT-602, a Novel PBD Dimer–containing Antibody–Drug Conjugate for Treating CD22-positive Hematologic Malignancies. Molecular Cancer Therapeutics. 23(4). 520–531. 6 indexed citations

Sartori, Giulio, Chiara Tarantelli, Filippo Spriano, et al.. (2023). The ATR inhibitor elimusertib exhibits anti‐lymphoma activity and synergizes with the PI3K inhibitor copanlisib. British Journal of Haematology. 204(1). 191–205. 7 indexed citations

Johnson, Zoë, Chiara Tarantelli, Luciano Cascione, et al.. (2023). IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance. Cancer Research Communications. 3(4). 576–591. 10 indexed citations

Tarantelli, Chiara & Francesco Bertoni. (2023). Bimiralisib. Phosphatidylinositol 3-kinase (PI3K)/mechanistic target of rapamycin (mTOR) inhibitor, Treatment of solid tumors, Treatment of lymphoma. Drugs of the Future. 48(3). 155–164. 1 indexed citations

Guidetti, Francesca, Alberto J. Arribas, Giulio Sartori, et al.. (2023). Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors. Journal of Clinical Medicine. 12(2). 399–399. 10 indexed citations

Carlo‐Stella, Carmelo, et al.. (2023). Highly Selective Allosteric Modulator of the Phosphoinositide 3‐Kinase Delta (PI3Kδ) Roginolisib In Patients With Refractory/Relapsed Follicular Lymphoma. Hematological Oncology. 41(S2). 574–574.

Barreca, Marilia, Virginia Spanò, Roberta Rocca, et al.. (2022). Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas. European Journal of Medicinal Chemistry. 243. 114744–114744. 34 indexed citations

10.

Barreca, Marilia, Virginia Spanò, Maria Valeria Raimondi, et al.. (2021). Recurrence of the oxazole motif in tubulin colchicine site inhibitors with anti-tumor activity. SHILAP Revista de lepidopterología. 1. 100004–100004. 22 indexed citations

11.

Mensah, Afua A., Filippo Spriano, Giulio Sartori, et al.. (2021). Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors. Blood Advances. 5(10). 2467–2480. 12 indexed citations

12.

Cascione, Luciano, Chiara Tarantelli, Andrea Rinaldi, et al.. (2021). Exon–Intron Differential Analysis Reveals the Role of Competing Endogenous RNAs in Post-Transcriptional Regulation of Translation. Non-Coding RNA. 7(2). 26–26. 3 indexed citations

13.

Jessen‐Trefzer, Claudia, Dimitrios Spiliotopoulos, Eugenio Gaudio, et al.. (2020). Understanding the mechanism of action of pyrrolo[3,2-b]quinoxaline-derivatives as kinase inhibitors. RSC Medicinal Chemistry. 11(6). 665–675. 6 indexed citations

14.

Lupi, Monica, Rosaria Chilà, Chiara Tarantelli, et al.. (2019). DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell Lymphomas. Molecular Cancer Therapeutics. 18(7). 1255–1264. 29 indexed citations

15.

Hicks, Stuart W., Chiara Tarantelli, Eugenio Gaudio, et al.. (2019). The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models. Haematologica. 104(8). 1633–1639. 18 indexed citations

16.

Fallacara, Anna Lucia, Mattia Mori, Francesca Musumeci, et al.. (2019). Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines. European Journal of Medicinal Chemistry. 181. 111545–111545. 14 indexed citations

17.

Tarantelli, Chiara, Elena Bernasconi, Eugenio Gaudio, et al.. (2018). BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance. ESMO Open. 3(6). e000387–e000387. 21 indexed citations

18.

Boi, Michela, Eugenio Gaudio, Paola Bonetti, et al.. (2015). The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs. Clinical Cancer Research. 21(7). 1628–1638. 214 indexed citations

19.

Mincione, Gabriella, Chiara Tarantelli, Giovina Vianale, et al.. (2014). Mutual regulation of TGF-β1, TβRII and ErbB receptors expression in human thyroid carcinomas. Experimental Cell Research. 327(1). 24–36. 10 indexed citations

20.

Reale, Marcella, P Boscolo, Chiara Tarantelli, et al.. (2011). Daily intake ofLactobacillus caseiShirota increases natural killer cell activity in smokers. British Journal Of Nutrition. 108(2). 308–314. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact